Hemp Collective

Hemp Collective podcast episode 12

Hemp Collective — Mon, 21 Dec 2020 11:00:00 -0500

Did you attend the Hemp Collective Virtual Summit II on December 9th? Did you miss it but wish you hadn't? There is no question in anyone's mind that 2020 was a year like no other, and that was certainly apparent in the hemp industry 2021.

Whether you're looking for a refresher form the recent Summit or missed it and want to plug in on key issues, you don't want to miss this podcast.

Join Summit co-MCs Todd Runestad and Fran Schoenwetter as they touch upon key take-aways you need to know to position your business for success.

If you want plug into the full Summit II content you can still access it HERE

What you need to know: Hemp CBD regulatory priorities for 2021

Hemp Collective — Fri, 04 Dec 2020 10:45:00 -0500

It goes without saying that 2021 has been a sea change year for everyone in all industry sectors, and impacts on the hemp CBD market have reverberated. Supply chain gluts contracted with more focused demand, and competition for more limited consumer spending and retail access has been felt by suppliers and brands alike. One are that has continue to power forward is the election and potential movement in regulations.

During this Hemp Collective podcast episode, we explore:

What impact the incoming Biden administration may pose for industry.
An exploration of new states CBD regulations recently adopted.
FDA, through the Trump administration, recently submitted its FY2021 budget request to Congress. How may that impact funding for CBD?
Regulatory impacts for brands - what they need to prioritize for 2021 to remain healthy.
Regulatory priorities for consumer protection and safety

Hemp Collective podcast episode 10: The wellness awakening in modern society, how hemp supports these values

Hemp Collective — Tue, 03 Nov 2020 15:00:00 -0500

Since the 1960's, when we saw the origins of the natural product industry emerge partly as a reaction to the "miracle" of processed foods and partly because of greater affluence throughout much of society, a wellness awakening has been slowly emerging. With a pandemic and global warming effects afflicting the world, consumers' focus on self care and conscious business as only accelerated.

How does hemp and hemp CBD play into shifting values and greater awareness about our personal and planetary wellness? We asked these question or Deanie Elsner, CEO of Charlotte's Web, and Erin Meagher, Founder of supplier Beneficial Blends what they believe is feeding changing attitudes and what they think the future has in store for the hemp CBD industry. Learn about why mission and commitments behind the scenes matter today more than ever.

Episode 9: The changing finance and investment landscape of hemp CBD

Hemp Collective — Fri, 09 Oct 2020 09:00:00 -0500

The adage "there's nothing constant but change" could not be more accurate when it comes to describing the rapidly evolving hemp industry finance and investment environment. When the regulatory picture changed, providing a legal path to market for raw material providers and processors, branded products, and ancillary services, it seemed the flood gates opened up wide for investors of all types looking to cash-in on the what's turned into a 20th century gold rush.

As the industry has grown, and begun maturing, opportunities and appetites change. Couple that with a global pandemic placing new variables into play across all production and product sectors, new industry priorities have developed and volatility in supply chains has emerged.

Today we interview Patrick Rea, CEO and co-founder of CanopyBoulder, one of the most active investors in the cannabis industry. Since their founding in 2013, Patrick has led investments in over 115 companies in the hemp, CBD and ancillary cannabis tech space. He knows a thing or two about the where the industry has been, and thinks he has a pretty decent handle and where the money is heading.

During this episode, we explore:

What's changed over the years in the developing hemp CBD market, and where today's investors a prioritizing.
A dive into the investor community to understand the types of investors - activist, equity, seed capital
How 2020 industry course corrections in supply chains for hemp and hemp CBD have impacted the market for supply chain investment.
A view into factors affecting today's company valuations.
A bit of "futurecasting" - where the industry may be heading.

Episode 8: The role of clinical science and research in today's hemp extract industry

Hemp Collective — Thu, 03 Sep 2020 12:59:00 -0500

Creating beneficial products derived from hemp for health requires the same discipline that's been applied to all botanical supplements. What's new is that we are still in the early discovery stages with the cannabis plant and many in the industry are also new to the rigors of clinical evidence.

Understanding the activities of various plant components, as isolates and in full spectrum forms, requires systematic study and analysis. For the industry to blossom into its full potential, these practices are necessary to truly open new markets and to ensure the safety and evidence needed to support human healthy benefits and claims.

Our duel conversations with Ananda Hemp's John Ryan, and scientist Anthony Almada, made it clear that adhering to the scientific method and investing in well designed clinical trials are not options, but necessities for the building a quality sustainable hemp industry.

During this episode, we explore:

The return on investing in clinical research and trials.
Understand how research converts to practical use in the field.
Where the science needs to catch up to the market.
How building a sustainable business goes beyond cultivation tactics.
That composition claims are under as much scrutiny as health claims.
Why the scrutiny of peer reviewed published science is needed to support efficacy and ultimately support claims.

Episode 7: Quality supply chains, critical operations for a quality industry

Hemp Collective — Thu, 06 Aug 2020 15:42:11 -0500

Building a quality hemp CBD industry means assurance that supply chains are meeting the highest standards. Cultivation, seeds, raw material handling, extractions processes and manufacturing must all meet specification and GMPs. In an environment where FDA regulatory compliance is not absolutely clear, quality producers need to be flexible and attentive, where production and documentation, specifications, purity, identity and potency requirements must adhere to understood standards of other industries while the regulations take form. We spoke with Beneficial Blends CEO Erin Meagher and Bluebird Botanicals' Dave Sommer about the challenges and opportunities hemp CBD production and quality in an evolving landscape.

Episode 6: Creating a sustainable hemp industry supply to shelf

Hemp Collective — Mon, 29 Jun 2020 23:52:46 -0500

A sustainable hemp industry requires commitments to farms, farmers, seed stock and long-term thinking. Join us for our duel interview podcast where were speak with Nutiva's Chris Amsler about operating through core sustainability values, and EcoGen's Doug Watson about the importance of committed partnerships with farmers.

Episode 5: Hemp Collective Virtual Summit rewind

Hemp Collective — Mon, 08 Jun 2020 23:07:48 -0500

In this month's podcast, we provide a snapshot of the regulatory, quality, market data and industry action items covered during the Hemp Collective Virtual Summit in May. During this episode, we explore: How the hemp industry can unite around a common goal to advocate for regulatory progress. Key data points and consumer insights driving industry growth. Top issues related to quality and how responsible brands can raise the bar. The biggest legal challenges companies face today.

Episode 4: How top hemp and CBD companies are managing through COVID-19

Hemp Collective — Fri, 01 May 2020 16:45:51 -0500

In this month's Hemp Collective podcast, we had a series of inspiring conversations with our Hemp Collective partners to understand how this resilient industry is addressing the COVID-19 crisis. We caught up with industry leaders from Ananda Hemp, Balanced Health Botanicals, Beneficial Blends, Bluebird Botanicals, CV Sciences, Green Roads, Nutiva and SōRSE Technology to dig into their approaches to health and safety, community support, marketing through uncertainty, forging stronger industry partnerships and planning for the future.

Episode 3: Knowledge of manufacturing regulations drive a quality hemp industry

Hemp Collective — Wed, 01 Apr 2020 20:50:23 -0500

New Hope Network and Natural Products Insider have begun a year-long dive into what makes a responsible hemp industry across the supply chain. In our third Hemp Collective podcast episode, we talk to Claudia Lewis, Venable LLP co-chair FDA Group, and Michael Flemmens, VP science, SōRSE Technology, exploring the regulatory requirements and manufacturing practices required for producing the highest quality hemp CBD products. We discuss the priorities of FDA today, and we explore some of the nuances of understanding your customer, assuring you can deliver on your brand's quality promise as a manufacturers or with your co-manufacturers.

Episode 2: The power of the hemp plant

Hemp Collective — Fri, 28 Feb 2020 22:52:58 -0500

New Hope Network and Natural Products Insider have begun a year-long dive into what makes a responsible hemp industry across the supply chain. In our second Hemp Collective podcast episode, we talk to Miles Sarill, national educator for CV Sciences, and Holly Johnson, Ph.D., Chief Science Officer American Herbal Products Association, to explore what makes hemp such a unique plant, its multitude of applications and why industry must invest in science. Plus, we take a walk down memory lane to track this ingredient's rich history (and also give a pop quiz to some of our colleagues).

Episode 1: What does the future hold for hemp and CBD?

Hemp Collective — Wed, 12 Feb 2020 21:50:12 -0500

New Hope Network and Natural Products Insider has begun a year-long dive into what makes a responsible hemp industry across the supply chain. During this first Hemp Collective podcast episode, several of our resident hemp industry and regulatory experts, Todd Runestad, senior supplements editor; Josh Long, legal and regulatory editor; and Michelle Zerbib, standards director, weigh in on what's next. “If the farmers don’t succeed, if they don’t have a market, these [hemp-based] industries are not going to mature.” -Josh Long